Literature DB >> 31370831

Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.

Jiaxin Liu1, Zhao Liu2, Xiaozhi Zhang3, Tuotuo Gong4, Demao Yao5.   

Abstract

.

Entities:  

Year:  2019        PMID: 31370831      PMCID: PMC6669972          DOI: 10.1186/s12885-019-5937-1

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


× No keyword cloud information.
Correction to: BMC Cancer (2019) 19:227 https://doi.org/10.1186/s12885-019-5406-x Following publication of the original article [1], the authors reported that Fig. 3 was incorrectly published with two “b” labels. The corrected figure is given below.
Fig. 3

Immunohistochemical staining of OLFML2B in gastric specimens. Matched (a) and (b), high expression of OLFML2B in GC and low expression in NG tissues; Matched (c) and (d), low expression of OLFML2B in GC tissues and high expression in NG; Matched (e) and (f), low expression of OLFML2B in GC and NG; Matched (g) and (h), there was no statistical difference between GC and NG tissues. Left: GC tissues (× 400); Right: NG tissues (× 400)

Immunohistochemical staining of OLFML2B in gastric specimens. Matched (a) and (b), high expression of OLFML2B in GC and low expression in NG tissues; Matched (c) and (d), low expression of OLFML2B in GC tissues and high expression in NG; Matched (e) and (f), low expression of OLFML2B in GC and NG; Matched (g) and (h), there was no statistical difference between GC and NG tissues. Left: GC tissues (× 400); Right: NG tissues (× 400) The original article [1] has been corrected.
  1 in total

1.  Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.

Authors:  Jiaxin Liu; Zhao Liu; Xiaozhi Zhang; Tuotuo Gong; Demao Yao
Journal:  BMC Cancer       Date:  2019-03-13       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.